Priorities for the Priority Review Voucher.
Publication
, Journal Article
Ridley, DB
Published in: The American journal of tropical medicine and hygiene
January 2017
The U.S. Congress created the priority review voucher program in 2007 to encourage development of drugs for neglected diseases. Under the voucher program, the developer of a drug for a neglected or rare pediatric disease that is approved by the U.S. Food and Drug Administration receives a bonus priority review voucher for another drug. As of 2016, four vouchers have sold for an average price of $200 million. Recent experience with the voucher program indicates strengths and weaknesses of the program, as well as a need for legislative changes.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The American journal of tropical medicine and hygiene
DOI
EISSN
1476-1645
ISSN
0002-9637
Publication Date
January 2017
Volume
96
Issue
1
Start / End Page
14 / 15
Related Subject Headings
- United States Food and Drug Administration
- United States
- Tropical Medicine
- Tropical Medicine
- Pharmaceutical Preparations
- Orphan Drug Production
- Neglected Diseases
- Humans
- Drug Discovery
- Drug Approval
Citation
APA
Chicago
ICMJE
MLA
NLM
Ridley, D. B. (2017). Priorities for the Priority Review Voucher. The American Journal of Tropical Medicine and Hygiene, 96(1), 14–15. https://doi.org/10.4269/ajtmh.16-0600
Ridley, David B. “Priorities for the Priority Review Voucher.” The American Journal of Tropical Medicine and Hygiene 96, no. 1 (January 2017): 14–15. https://doi.org/10.4269/ajtmh.16-0600.
Ridley DB. Priorities for the Priority Review Voucher. The American journal of tropical medicine and hygiene. 2017 Jan;96(1):14–5.
Ridley, David B. “Priorities for the Priority Review Voucher.” The American Journal of Tropical Medicine and Hygiene, vol. 96, no. 1, Jan. 2017, pp. 14–15. Epmc, doi:10.4269/ajtmh.16-0600.
Ridley DB. Priorities for the Priority Review Voucher. The American journal of tropical medicine and hygiene. 2017 Jan;96(1):14–15.
Published In
The American journal of tropical medicine and hygiene
DOI
EISSN
1476-1645
ISSN
0002-9637
Publication Date
January 2017
Volume
96
Issue
1
Start / End Page
14 / 15
Related Subject Headings
- United States Food and Drug Administration
- United States
- Tropical Medicine
- Tropical Medicine
- Pharmaceutical Preparations
- Orphan Drug Production
- Neglected Diseases
- Humans
- Drug Discovery
- Drug Approval